SCHEMBL31599996

SCHEMBL31599996

CC(C)(C)OC(=O)N1CCc2c(Br)cc(Cl)nc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 2/20 0.41
▸ USP30 Q70CQ3 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.37
▸ HSP90AB1 P08238 1/20 0.37
▸ GPR119 Q8TDV5 3/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ KCNH2 Q12809 2/20 0.34
▸ STS P08842 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ CHRNA7 P36544 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ MKNK1 Q9BUB5 2/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ NR1H2 P55055 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31600662 0.85 ESR2 (0.38) UCHL1USP30HSP90AA1HSP90AB1GPR119
SCHEMBL31514682 0.78 POLB (0.37) UCHL1GPR119ESR2STSPOLB
SCHEMBL30746650 0.77 UCHL1 (0.47) UCHL1USP30GPR119POLBCHRNA7
SCHEMBL21855821 0.77 UCHL1 (0.47) UCHL1USP30GPR119POLBCHRNA7
SCHEMBL21166288 0.77 GPR119 (0.39) UCHL1USP30HSP90AA1HSP90AB1GPR119
SCHEMBL31600449 0.75 NR1H2 (0.36) UCHL1USP30HSP90AA1HSP90AB1GPR119
SCHEMBL21143651 0.75 MTOR (0.42) —
SCHEMBL31127096 0.75 MTOR (0.42) —
SCHEMBL18181095 0.74 ESR2 (0.44) HSP90AA1HSP90AB1GPR119ESR2POLB
SCHEMBL30513272 0.74 POLB (0.41) UCHL1GPR119ESR2POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111547-A1 2,3-DIHYDROPYROLLOPYRIDINE CARBOXAMIDE COMPOUNDS AND METHODS OF USE THEREOF RGENTA THERAPEUTICS, INC. (US) 2025-05-30 — — WO disclosed
Send feedback